Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of 'Bulk drugs and chemicals. The company is part of the SK Group with the key products including antibiotics, erythromycin salts, chloramphenicol and other chemicals. It is well positioned to service its existing and potential markets through its manufacturing operations at Tarapur in Maharashtra.
The Company was incorporated on February 19, 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs.
The business headquarters of the firm is located in the commercial capital of India, Mumbai. The company is a recognized export house and exports their products to Mexico, Brazil, Iran, Bangladesh, Colombia, Germany, Africa, Singapore and several other countries.
During the year 2006-07, the company commissioned the new plant with all latest modern techniques and facilities. Thus, the production capacity of Antibiotics increased from 400,000 Kg to 600,000 Kg.
During the year 2008-09, the company completed the on-going expansion of their plant, thus they increased the installed capacity by 150 MT per annum. In September 2008, they expanded unit started commercial production.
In January 2010, the c ...ompany received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption.
In April 2010, the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption.
In June 2010, the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines & Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption.
The erection of a new plant for manufacture of drug intermediates, was completed during the year 2010-11 and it got commissioned towards end of February, 2011.
In 2012, it received WHO - PQ for Pyrazinamide & acquired R&D assets in Mahape, Navi Mumbai & got DSIR approval. In 2014, it got approval from COFEPRIS - Mexico for Erythromycin Estolate, Erythromycin Stearate, Erythromycin Ethyl Succinate. In 2015, it received approval of WHO - PQ for Sulfadoxine.
In March 2019, the Company opened new expansion with an additional capacity of 900 MTPA for 20 different products. It commissioned the new expansion project by starting commercial production in December, 2019.
It received CEP for Ambroxol Hydrochloride from EDQM in 2022. In FY 2023-24, Company enhanced production capacity from 1,500 MTPA to 1,800 MTPA at Boisar site.
In FY 2025, Company made strong progress with the launch of six new products, adding 40 new export customers and partnerships, and further strengthening its regulatory foundation. The Company steadily expanded its infrastructure by operating a total of 9 API blocks and 2 intermediate blocks, bringing the total installed capacity to 2,400 metric tons per annum in FY 2025.
FAQs on Anuh Pharma Ltd
1. Can I buy Anuh Pharma Ltd from PL Capital? ›
Yes, you can invest in Anuh Pharma Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Anuh Pharma Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Anuh Pharma Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Anuh Pharma Ltd pay dividends? ›
Yes, Anuh Pharma Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Anuh Pharma Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.
3. What is the current share price of Anuh Pharma Ltd ? ›
As of
05-Feb-2026 , 15:42:53 the share price for Anuh Pharma Ltd. is ₹ 79.78 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Anuh Pharma Ltd ? ›
The 52-week high and low of Anuh Pharma Ltd share price is ₹ 69.27 - ₹ 114.9 as of
05-Feb-2026 , 15:42:53 .
